Press Releases

In a major win for seniors and patients struggling to afford their necessary medications, on Monday a U.S. District Judge rejected lawsuits from Bristol Myers Squibb and Johnson & Johnson seeking to block the Inflation Reduction Act’s measures giving Medicare the power to negotiate lower prices directly with drug manufacturers.

Pharmaceutical giant Eli Lilly reported $2.24 billion in Q1 2024 earnings today, with revenue increasing by 26% from the previous year.

Outside of the White House Correspondents’ Dinner last night, government watchdog Accountable.US projected a new digital ad with the message, “Texas decisions, national consequences: Find out how the US Chamber of Commerce picks judges and how Texas court rulings affect all of us, no matter where you are,” calling out the Fifth Circuit Court of App

Today, pharmaceutical giant AbbVie reported $12.31 billion in revenue in Q1 2024 — all while remaining opposed to a Biden administration program designed to bring down drug prices for consumers. AbbVie CEO Richard Gonzalez has been a vocal critic of Medicare’s new negotiation authority, arguing that the ability to negotiate lower drug costs for pat

Within two days of the Federal Trade Commission (FTC) finalizing its new rule banning noncompetes nationwide to open the door for up to $488 billion in increased worker earnings over the next decade, the agency is already facing lawsuits from right-wing special interests in two Texas federal courts that both fall under the jurisdiction of the conse